Basic Study
Copyright ©The Author(s) 2020.
World J Diabetes. Jun 15, 2020; 11(6): 239-251
Published online Jun 15, 2020. doi: 10.4239/wjd.v11.i6.239
Figure 1
Figure 1 Increased macrophage migration to pancreatic islet cells with the reduction of CD47 expression under streptozotocin treatment. A: The experimental design. Mice were treated by five daily intraperitoneal injections of streptozotocin (STZ) to construct a diabetes model; B: Macrophage infiltration into pancreatic islet cells which was indicated by increased F4/80 labeling accompanied by decreased insulin secretion in STZ treated cells; C: Statistical data; D and E: CD47 expression decreased under STZ condition. Student's t-test was performed. aP < 0.01 vs CTL. CD47: Cluster of differentiation 47; STZ: Streptozotocin; CFSE: Carboxy fluorescein succinimidyl ester.